SCHEMBL26342736

SCHEMBL26342736

c1ccc2c(N(c3ccc4c(c3)oc3cc5c(cc34)oc3cc4c(cc35)oc3cc(N(c5ccc6oc7ccccc7c6c5)c5cccc6ccccc56)ccc34)c3ccc4oc5ccccc5c4c3)cccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.41
▸ KDM4E B2RXH2 6/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ HPGD P15428 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ AHR P35869 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ DUSP3 P51452 1/20 0.40
▸ GAA P10253 2/20 0.36
▸ NISCH Q9Y2I1 1/20 0.36
▸ TDP1 Q9NUW8 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MAOA P21397 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17637178 0.94 AHR (0.45) MAPTKDM4EALDH1A1KMT2AHPGD
SCHEMBL21968724 0.93 KDM4E (0.38) MAPTKDM4EALDH1A1KMT2AHPGD
SCHEMBL17126369 0.93 KDM4E (0.41) MAPTKDM4EALDH1A1KMT2AHPGD
SCHEMBL21966511 0.92 KDM4E (0.37) MAPTKDM4EALDH1A1KMT2AHPGD
SCHEMBL26046151 0.92 KDM4E (0.40) MAPTKDM4EALDH1A1KMT2AHPGD
SCHEMBL17126348 0.90 KDM4E (0.41) MAPTKDM4EALDH1A1KMT2AHPGD
SCHEMBL18802547 0.90 MAPT (0.37) MAPTKDM4EALDH1A1KMT2AHPGD
SCHEMBL24372696 0.89 KDM4E (0.41) MAPTKDM4EALDH1A1KMT2AHPGD
SCHEMBL14295286 0.89 AHR (0.41) MAPTKDM4EALDH1A1KMT2AHPGD
SCHEMBL14295276 0.89 KDM4E (0.41) MAPTKDM4EALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230309385-A1 ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, DISPLAY DEVICE, LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-09-28 — — US disclosed
US-20230309385-A1 ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, DISPLAY DEVICE, LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230309385-A1 ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, DISPLAY DEVICE, LIGHTING DEVICE DDT, SLC43A1, SLCO2B1 MAPT 1064/4885KDM4E 3051/4885ALDH1A1 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback